A Government Accountability Office report finding “substantially higher” Medicare Part B drug spending among 340B-participating hospitals compared to non-340B hospitals recommends that Congress take action to eliminate the financial incentives that promote the higher spending.
Released July 6, the GAO report found that “in both 2008 and 2012, per beneficiary Medicare Part B...